- Home
- GPCR vs PGRE Comparison
GPCR vs PGRE Comparison
Compare GPCR & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- PGRE
- Stock Information
- Founded
- GPCR 2016
- PGRE 1978
- Country
- GPCR United States
- PGRE United States
- Employees
- GPCR N/A
- PGRE N/A
- Industry
- GPCR
- PGRE Real Estate Investment Trusts
- Sector
- GPCR
- PGRE Real Estate
- Exchange
- GPCR Nasdaq
- PGRE Nasdaq
- Market Cap
- GPCR 1.1B
- PGRE 991.9M
- IPO Year
- GPCR 2023
- PGRE 2014
- Fundamental
- Price
- GPCR $23.20
- PGRE $4.34
- Analyst Decision
- GPCR Strong Buy
- PGRE Hold
- Analyst Count
- GPCR 8
- PGRE 3
- Target Price
- GPCR $80.71
- PGRE $4.33
- AVG Volume (30 Days)
- GPCR 1.3M
- PGRE 3.1M
- Earning Date
- GPCR 05-08-2025
- PGRE 04-30-2025
- Dividend Yield
- GPCR N/A
- PGRE 0.80%
- EPS Growth
- GPCR N/A
- PGRE N/A
- EPS
- GPCR N/A
- PGRE N/A
- Revenue
- GPCR N/A
- PGRE $710,365,000.00
- Revenue This Year
- GPCR N/A
- PGRE $2.60
- Revenue Next Year
- GPCR N/A
- PGRE N/A
- P/E Ratio
- GPCR N/A
- PGRE N/A
- Revenue Growth
- GPCR N/A
- PGRE 50.61
- 52 Week Low
- GPCR $13.22
- PGRE $3.75
- 52 Week High
- GPCR $62.74
- PGRE $5.47
- Technical
- Relative Strength Index (RSI)
- GPCR 64.61
- PGRE 57.30
- Support Level
- GPCR $17.94
- PGRE $4.03
- Resistance Level
- GPCR $24.17
- PGRE $4.47
- Average True Range (ATR)
- GPCR 1.81
- PGRE 0.17
- MACD
- GPCR 1.08
- PGRE 0.04
- Stochastic Oscillator
- GPCR 89.94
- PGRE 84.72
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. Paramount Group derives nearly all of its revenue in the form of rental income from leasing its offices to tenants.